Please login to the form below
EFPIA appoints new director general
Nathalie Moll takes up the role from April
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has named Nathalie Moll as its new director general, set to take over from interim director general Eric Cornut in April.
Based in Brussels, Belgium, Moll has been secretary general of EuropaBio, the European Association for Bioindustries, since 2010.
She first joined the trade body in 1999 as manager for external and government affairs, and re-joined in 2005 as director for healthcare and strategic policy. She was subsequently promoted to executive director for green biotechnology, Europe in 2006 before taking on her current role.
Joe Jiminez, president of EFPIA, said: “Nathalie has an excellent track record of leadership and engagement across the life science sector.
“We are confident she is the right person to lead EFPIA, working with stakeholders to address the challenges faced by healthcare systems in Europe.”
Subscribe to our email news alerts
- Actinic keratosis – a common skin condition that can lead to skin cancer
- The paper trail
- Medscape Education’s Large Presence at IDWeek 2023
- WHO recommends second malaria vaccine for children
- Sanofi enters agreement with Janssen to develop E. coli vaccine candidate
- NFID and CDC urge US adults to get vaccinated against flu and COVID-19
No results were found
PMHub
Twist Health
Not just another healthcare communications agency. We are a collection of award-winning industry experts focusing on bringing the very best...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
